Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors.

Birkenbach M, Josefsen K, Yalamanchili R, Lenoir G, Kieff E.

J Virol. 1993 Apr;67(4):2209-20.

3.
4.

Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells.

Kuhn-Hallek I, Sage DR, Stein L, Groelle H, Fingeroth JD.

Blood. 1995 Mar 1;85(5):1289-99.

5.
6.
7.
8.

LMP-1, the Epstein-Barr virus-encoded oncogene with a B cell activating mechanism similar to CD40.

Klein E, Teramoto N, Gogolák P, Nagy N, Björkholm M.

Immunol Lett. 1999 May 3;68(1):147-54. Review.

PMID:
10397170
9.

Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines.

Palmero I, Holder A, Sinclair AJ, Dickson C, Peters G.

Oncogene. 1993 Apr;8(4):1049-54.

PMID:
8455931
10.

Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein.

Mosialos G, Yamashiro S, Baughman RW, Matsudaira P, Vara L, Matsumura F, Kieff E, Birkenbach M.

J Virol. 1994 Nov;68(11):7320-8.

11.
12.

Biochemistry of latent Epstein-Barr virus infection and associated cell growth transformation.

Kieff E, Hennessy K, Fennewald S, Matsuo T, Dambaugh T, Heller M, Hummel M.

IARC Sci Publ. 1985;(60):323-39.

PMID:
2998995
13.

Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.

Wang D, Liebowitz D, Wang F, Gregory C, Rickinson A, Larson R, Springer T, Kieff E.

J Virol. 1988 Nov;62(11):4173-84.

14.

The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus.

Hollyoake M, Stühler A, Farrell P, Gordon J, Sinclair A.

Cancer Res. 1995 Nov 1;55(21):4784-7.

15.

Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination.

Walter J, Schirrmacher V, Mosier D.

Int J Cancer. 1995 May 4;61(3):363-9. Erratum in: Int J Cancer 1995 Oct 9;63(2):318.

PMID:
7537255
16.
17.

Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.

Cordier M, Calender A, Billaud M, Zimber U, Rousselet G, Pavlish O, Banchereau J, Tursz T, Bornkamm G, Lenoir GM.

J Virol. 1990 Mar;64(3):1002-13.

18.

Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2.

Burgstahler R, Kempkes B, Steube K, Lipp M.

Biochem Biophys Res Commun. 1995 Oct 13;215(2):737-43.

PMID:
7488016
19.

Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV).

Calender A, Cordier M, Billaud M, Lenoir GM.

Int J Cancer. 1990 Oct 15;46(4):658-63.

PMID:
1698730

Supplemental Content

Support Center